ideology-health
  • Our Solutions
  • About Us
    • ideology-health
    Privacy Policy
    Terms of Service

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    H

    Dr Hossein Borghaei, MD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Hossein Borghaei shows the 6-year results of nivo/ipi + chemo in mNSCLC in patients with squamous histology and high-risk mutations. (Video 2/3)

    Dr. Hossein Borghaei shows the 6-year results of nivo/ipi + chemo in mNSCLC in patients with squamous histology and high-risk mutations. (Video 2/3)

    CM-9LA Biomarker

    Hossein Borghaei, MD
    Lung Cancer
    Dr. Hossein Borghaei discusses the 6-year efficacy of nivo/ipi + chemo in PD-L1 negative mNSCLC. (Video 1/3)

    Dr. Hossein Borghaei discusses the 6-year efficacy of nivo/ipi + chemo in PD-L1 negative mNSCLC. (Video 1/3)

    CM-9LA PD-L1 Negative

    Hossein Borghaei, MD
    Lung Cancer